REQUEST A DEMO
Total
USD $0.00
Search more companies

Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Klovermed Severo-Zapad OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) is a company in Russia, with a head office in Saint Petersburg. It operates in the Pharmacies and Drug Stores sector. The company was established on October 05, 2015. In its most recent financial highlights, the company reported a net sales revenue drop of 21.96% in 2024. Its’ total assets recorded a growth of 7.82%. The enterprise’s net profit margin decreased by 11.95% in 2024.

Headquarters
Marata, 47-49, A, S205
Saint Petersburg; Saint Petersburg; Postal Code: 191002

Contact Details: Purchase the Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) report to view the information.
Financial Auditors:
Purchase the Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) report to view the information.
Incorporation Date:
October 05, 2015
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Klovermed Severo-Zapad OOO (Кловермед Северо-Запад ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-21.96%
Total operating revenue
-21.96%
Operating profit (EBIT)
-55.01%
Net Profit (Loss) for the Period
-58.97%
Total Assets
7.82%
Total Equity
-58.71%
Operating Profit Margin (ROS)
-12.01%
Net Profit Margin
-11.95%
Return on Equity (ROE)
-0.62%
Quick Ratio
-0.45%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?